alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
HomeOffice of the SpokespersonPress Releases...Department of State Offers Reward for Information to Bring Two Kenyan Nationals to Justice

# 									Department of State Offers Reward for Information to Bring Two Kenyan Nationals to Justice							

Press Statement

Ned Price, Department Spokesperson

May 26, 2022

The U.S. Department of State is offering rewards of up to $1 million each for information leading to the arrests and/or convictions of two fugitive Kenyan nationals, Abdi Hussein Ahmed and Badru Abdul Aziz Saleh, for participating in, or conspiring to participate in, transnational organized crime. Ahmed has been charged in the United States with wildlife trafficking in violation of the Lacey Act and with conspiracy to commit wildlife trafficking in violation of the Endangered Species Act and Lacey Act. Fugitives Ahmed and Saleh have also been charged in the United States with conspiracy to distribute heroin. Additionally, Ahmed is charged in Uganda and Kenya with violations of the Uganda Wildlife Act, the Kenya Wildlife Conservation and Management Act, and the Kenya East Africa Customs Act.

Any information in response to the reward offer regarding Ahmed or Saleh should be directed to the U.S. Fish and Wildlife Service at +1-844-FWS-TIPS (+1-844-397-8477), Kenya Directorate of Criminal Investigations at +254(0)80072220 or by email at FWS_TIPS@fws.gov.

This reward is offered under the Department of State’s Transnational Organized Crime Rewards Program (TOCRP). The TOCRP and Narcotics Rewards Program (NRP) have helped bring more than 75 transnational criminals and major narcotics traffickers to justice since the inception of the NRP in 1986. The Department has paid more than $135 million in rewards under these programs for information leading to apprehensions and convictions.

The Bureau of International Narcotics and Law Enforcement Affairs manages the TOCRP in close coordination with federal law enforcement partners and other U.S. government agencies. These actions demonstrate the Department’s commitment to supporting law enforcement efforts to bring transnational criminals to justice.

For more information on the individuals listed above and the NRP and TOCRP, please see https://www.state.gov/bureau-of-international-narcotics-and-law-enforcement-affairs/inl-rewards-program/.

Tags

Bureau of African AffairsBureau of International Narcotics and Law Enforcement AffairsForeign Service InstituteKenyaNarcoticsOffice of the SpokespersonTransnational Organized Crime Rewards Program Targets

Back to Top
§ 408.60 Direct remittance: Basic rules. ( a ) Premiums not deducted from monthly benefits under Subpart C of this part or paid by a State buy-in agreement must be paid by direct remittance to CMS or its agents, by or on behalf of the enrollee.
( b ) Quarterly payment is preferred as more cost-effective, but monthly payment is accepted if the enrollee is unwilling or unable to make quarterly payments or is also paying hospital insurance premiums, which must be paid every month.
( c ) CMS, directly or through its agents, sends quarterly or monthly premium bills and includes an addressed return envelope with the bill.
( d ) The individual must— ( 1 ) Send a check or money order that is drawn payable to “CMS Medicare Insurance” and show the enrollee's name and claim number as it appears on the Medicare card; and
( 2 ) Return the bill with the check or money order in the preaddressed envelope.
HomeIceland

# Iceland

99 items

        -    		Economic Dialogues	   
        -    Air Transport Agreement  		Agreement To Remove Time Constraints on Air Carrier Leases of Aircraft With Crew Between the U.S., EU, Iceland, and Norway	  August 27, 2019 
        -    Report  		Iceland	  July 11, 2019 
        -    Report  		Iceland	  June 21, 2019 
        -    Report  		Iceland	  June 20, 2019 
        -    		Iceland	  April 24, 2019 
        -    TIAS  		Iceland (19-322) – Agreement Concerning Employment of Dependents of Official Employees	  March 22, 2019 
        -    Report  		Iceland	  March 13, 2019 
        -    TIAS  		Iceland (19-301) – Agreement on Social Security	  March 1, 2019 
        -    		Enhanced Partnership in Northern Europe (E-PINE)	   

previous page1…678910next page

Back to Top
#### § 403.1100 Purpose and scope.

The regulations in this subpart implement section 1115A of the Act. The intent of that section is to enable CMS to test innovative payment and service delivery models to reduce program expenditures while preserving and/or enhancing the quality of care furnished to individuals under titles XVIII, XIX, and XXI of the Act. The Secretary is also required to conduct an evaluation of each model tested.
<page>

                                                                    EXHIBIT 32.1

         WRITTEN STATEMENT OF THE CEO PURSUANT TO 18 S.S.C. SECTION 1350


                            CERITFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of PurchaseSoft, Inc. (the
"Company") on Form 10-QSB for the period ending February 28, 2007 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Steven A. Flagg, President of the Company, certify, solely for the purposes of
complying with 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

         1.      The report fully complies with the requirements of Section
                 13(a) or 15(d) of the Securities Exchange Act of 1934; and

         2.      The information contained in the Report fairly presents, in all
                 material respects, the financial condition and results of
                 operations of the Company as of August 31, 2006.

/s/ Steven A. Flagg
---------------------------
Steven A. Flagg, President and CEO
Dated: May 23, 2008
§ 408.71 Change from deduction or State payment to direct remittance. ( a ) *Basis for change.* An SMI enrollee is required to pay by direct remittance in any of the following circumstances: ( 1 ) The enrollee's entitlement to social security or railroad retirement benefits ends for any reason other than death.
( 2 ) The premiums can no longer be deducted from the civil service annuity of the enrollee or the enrollee's spouse.
( 3 ) The enrollee no longer qualifies for coverage under a State buy-in agreement, and is not entitled to social security or railroad retirement monthly benefits.
( b ) *Billing.* When any of the events specified in paragraph (a) of this section occurs (or as soon thereafter as possible), CMS or its agents bill the enrollee for direct remittance, in accordance with this subpart.
#### § 583.306 [Reserved]
I

104TH CONGRESS

2D SESSION H. R. 2937

For the reimbursement of legal expenses and related fees incurred by former

employees of the White House Travel Office with respect to the termination of their employment in that Office on May 19, 1993.

IN THE HOUSE OF REPRESENTATIVES

FEBRUARY 1, 1996

Mr. CLINGER (for himself, Mr. ARMEY, Mr. DELAY, Mr. WALKER, Mr. BURTON of Indiana, Mr. DAVIS, Mr. FOX of Pennsylvania, Mr. HASTERT, Mr.

SCHIFF, Mr. BLUTE, Mr. LATOURETTE, Mr. FRANK of Massachusetts,

Mrs. MORELLA, Mrs. VUCANOVICH, Mr. BALLENGER, and Mr. EHRLICH)

introduced the following bill; which was referred to the Committee on the

Judiciary

A BILL

For the reimbursement of legal expenses and related fees

incurred by former employees of the White House Travel

Office with respect to the termination of their employment in that Office on May 19, 1993.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. REIMBURSEMENT OF CERTAIN LEGAL EX4 PENSES AND RELATED FEES.

5 (a) IN GENERAL.—The Secretary of the Treasury

6 shall pay, from amounts in the Treasury not otherwise ap-
2

•HR 2937 IH

1 propriated, such sums as are necessary to reimburse

2 former employees of the White House Travel Office whose

3 employment in that Office was terminated on May 19,

4 1993, for any legal expenses and related fees they incurred

5 with respect to that termination.

6 (b) VERIFICATION REQUIRED.—The Secretary shall

7 pay an individual in full under subsection (a) upon sub8 mission by the individual of documentation verifying the

9 legal expenses and related fees.

10 (c) NO INFERENCE OF LIABILITY.—Liability of the

11 United States shall not be inferred from enactment of or

12 payment under this section.

Æ
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


      In connection with the quarterly report of Circuit Research Labs, Inc.
(the "Company") on Form 10-QSB for the period ending June 30, 2003, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Robert W. McMartin, Chief Financial Officer of the Company, certify, to
the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)  The Report fully complies with the requirements of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company
     for the periods presented.

                                       /s/ Robert W. McMartin
                                       ----------------------------
                                       Robert W. McMartin
                                       Chief Financial Officer
                                       Circuit Research Labs, Inc.
                                       August 20, 2003
§ 3.204 Privilege of patient safety work product. ( a ) *Privilege.* Notwithstanding any other provision of Federal, State, local, or Tribal law and subject to paragraph (b) of this section and § 3.208 of this subpart, patient safety work product shall be privileged and shall not be: ( 1 ) Subject to a Federal, State, local, or Tribal civil, criminal, or administrative subpoena or order, including in a Federal, State, local, or Tribal civil or administrative disciplinary proceeding against a provider;
( 2 ) Subject to discovery in connection with a Federal, State, local, or Tribal civil, criminal, or administrative proceeding, including in a Federal, State, local, or Tribal civil or administrative disciplinary proceeding against a provider;
( 3 ) Subject to disclosure pursuant to section 552 of Title 5, United States Code (commonly known as the Freedom of Information Act) or any other similar Federal, State, local, or Tribal law;
( 4 ) Admitted as evidence in any Federal, State, local, or Tribal governmental civil proceeding, criminal proceeding, administrative rulemaking proceeding, or administrative adjudicatory proceeding, including any such proceeding against a provider; or
( 5 ) Admitted in a professional disciplinary proceeding of a professional disciplinary body established or specifically authorized under State law.
( b ) *Exceptions to privilege.* Privilege shall not apply to (and shall not be construed to prohibit) one or more of the following disclosures: ( 1 ) Disclosure of relevant patient safety work product for use in a criminal proceeding, subject to the conditions at § 3.206(b)(1) of this subpart.
( 2 ) Disclosure to the extent required to permit equitable relief subject to the conditions at § 3.206(b)(2) of this subpart.
( 3 ) Disclosure pursuant to provider authorizations subject to the conditions at § 3.206(b)(3) of this subpart.
( 4 ) Disclosure of non-identifiable patient safety work product subject to the conditions at § 3.206(b)(5) of this subpart.
( c ) *Implementation and enforcement by the Secretary.* Privilege shall not apply to (and shall not be construed to prohibit) disclosures of relevant patient safety work product to or by the Secretary if such patient safety work product is needed to investigate or determine compliance, or to seek or impose civil money penalties, with respect to this part or the HIPAA Privacy Rule, or to make or support decisions with respect to listing of a PSO.
#### § 6.15 Agency review.

Either the applicant or agency counsel may seek review of the initial decision on the fee application, or the agency may decide to review the decision on its own initiative. If neither the applicant nor agency counsel seeks a review and the agncy does not take review on its own initiative, the initial decision on the application shall become a final decision of the agency 30 days after it is issued. Whether to review a decision is a matter within the discretion of the agency. If review is taken, the agency will issue a final decision on the application or remand the application to the adjudicative officer for further proceedings.
# C_2005155EN.01000701.xml

| 25.6.2005 | EN | Official Journal of the European Union | C 155/7 |
| --- | --- | --- | --- |

25.6.2005

EN

Official Journal of the European Union

C 155/7

---

Action brought on 19 April 2005 by Commission of the European Communities against Ireland

(Case C-175/05)

(2005/C 155/13)

Language of the case: English

An action against Ireland was brought before the Court of Justice of the European Communities on 19 April 2005 by the Commission of the European Communities, represented by Michael Shotter and Wouter Wils, acting as Agents, with an address for service in Luxembourg.

The applicant claims that the Court should:

| 1. | declare that by exempting all categories of public lending establishments, within the meaning of Council Directive 92/100/EEC of 19 November 1992 on rental right and lending right and on certain rights related to copyright in the field of intellectual property (1), Ireland has failed to fulfil its obligations under Articles 1 and 5 of that Directive; |
| --- | --- |

1.

declare that by exempting all categories of public lending establishments, within the meaning of Council Directive 92/100/EEC of 19 November 1992 on rental right and lending right and on certain rights related to copyright in the field of intellectual property (1), Ireland has failed to fulfil its obligations under Articles 1 and 5 of that Directive;

1

| 2. | order Ireland to pay the costs. |
| --- | --- |

2.

order Ireland to pay the costs.

Pleas in law and main arguments

Article 1(3) of the Directive defines ‘lending’ in terms of making available for use, for a limited period of time and not for direct or indirect economic or commercial advantage ‘when it is made through establishments which are accessible to the public’. Article 5(3) allows Member States to exempt ‘certain categories of establishments’ from the payment of remuneration.

The Irish authorities have relied upon Article 5(3) of the Directive and exempted by Order ‘stated classes of institutions from payment of remuneration in respect of lending in practice’. The scope of this exemption is so wide that it permits all public educational and academic institutions to which the members of the public have access to engage in public lending with the result that all public lending institutions are exempt from the lending right and are also absolved from payment of remuneration.

The Commission maintains that this situation clearly goes beyond the scope of the exceptions permitted by Article 5(3) of the Directive and that Ireland therefore has failed to fulfil its obligations under Articles 1 and 5 of the Directive.

---

(1)  OJ L 346, 27.11.1992, p. 61

1

---
Editorial Note on Part 409
Editorial Note: Nomenclature changes to part 409 appear at 62 FR 46037, Aug. 29, 1997.

§ 409.80 Inpatient deductible and coinsurance: General provisions. ( a ) *What they are.* ( 1 ) The inpatient deductible and coinsurance amounts are portions of the cost of covered hospital or CAH or SNF services that Medicare does not pay.
( 2 ) The hospital or CAH or SNF may charge these amounts to the beneficiary or someone on his or her behalf.
( b ) *Changes in the inpatient deductible and coinsurance amounts.* ( 1 ) The law requires the Secretary to adjust the inpatient hospital deductible each year to reflect changes in the average cost of hospital care. In adjusting the deductible, the Secretary must use a formula specified in section 1813(b)(2) of the Act. Under that formula, the inpatient hospital deductible is increased each year by about the same percentage as the increase in the average Medicare daily hospital costs. The result of the deductible increase is that the beneficiary continues to pay about the same proportion of the hospital bill.
( 2 ) Since the coinsurance amounts are, by statute, specific fractions of the deductible, they change when the deductible changes.
[48 FR 12541, Mar. 25, 1983, as amended at 58 FR 30666, May 26, 1993]
§ 136.406 Under what circumstances will the minimum standards of character be considered to be met? The minimum standards of character shall be considered met only after the individual has been the subject of a satisfactory background investigation. The background investigation shall include a review of: ( a ) The individual's trustworthiness, through inquiries with the individual's references and places of employment and education;
( b ) A criminal history background check, which includes a fingerprint check through the Criminal Justice Information Services Division of the Federal Bureau of Investigation (FBI), under procedures approved by the FBI, and inquiries to State and Tribal law enforcement agencies for the previous five years of residence listed on the individual's application; and
( c ) A determination as to whether the individual has been found guilty of or entered a plea of nolo contendere or guilty to any felonious offense or any of two or more misdemeanor offenses under Federal, State, or Tribal law involving crimes of violence; sexual assault, molestation, exploitation, contact, or prostitution; crimes against persons; or offenses committed against children.
HomeSerbia

# Serbia

125 items

        -    Press Statement  		Welcoming the Agreement between Kosovo and Serbia	  Ned PriceNovember 23, 2022 
        -    Press Statement  		The United States Urges Kosovo and Serbia to Take Immediate Steps to De-Escalate Tensions	  Ned PriceNovember 21, 2022 
        -    Department Press Briefing  		Department Press Briefing – November 8, 2022	  Ned PriceNovember 8, 2022Washington, D.C. 
        -    Press Statement  		The U.S. Urges Kosovo to Extend License Plate Implementation Deadline	  Ned PriceOctober 28, 2022 
        -    Department Press Briefing  		Department Press Briefing – October 24, 2022	  Ned PriceOctober 24, 2022Washington, DC 
        -    Department Press Briefing  		Department Press Briefing – October 19, 2022	  Vedant PatelOctober 19, 2022Washington, D.C. 
        -    Department Press Briefing  		Department Press Briefing – October 12, 2022	  Ned PriceOctober 12, 2022Washington, DC 
        -    Readout  		Secretary Blinken’s Call with Serbian President Vucic	  October 11, 2022 
        -    Department Press Briefing  		Department Press Briefing – August 29, 2022	  Vedant PatelAugust 25, 2022Washington, DC 
        -    Special Briefing  		Special Online Briefing with Ambassador Bonnie Denise Jenkins, Under Secretary for Arms Control and International Security	  Bonnie Denise JenkinsAugust 25, 2022 

previous page1…56789…13next page

Back to Top
Exhibit
32.1 CERTIFICATE PURSUANT TO


18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002








Each of the undersigned hereby
certifies in his capacity as an officer of InMedica Development Corporation (the
Company) that the Quarterly Report of the Company on Form 10Q for the quarter
ended June 30, 2008 fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 and that the information contained in such
report fairly presents, in all material respects, the financial condition of the
Company at the end of such periods and the results of operations of the Company
for such periods.








/s/ Ralph
Henson


Ralph
Henson,


Chief
Executive Officer


August
13, 2008








/s/ Richard
Bruggeman


Richard
Bruggeman,


Chief
Financial Officer


August
13, 2008
I

104TH CONGRESS

2D SESSION H. R. 2870

To eliminate the duties on Tetraamino Biphenyl.

IN THE HOUSE OF REPRESENTATIVES

JANUARY 23, 1996

Mr. ZIMMER introduced the following bill; which was referred to the

Committee on Ways and Means

A BILL

To eliminate the duties on Tetraamino Biphenyl.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. ELIMINATION OF DUTIES ON

4 3,3′-DIAMINOBENZIDINE (TETRAAMINO

5 BIPHENYL).

6 (a) ELIMINATION OF DUTIES.—The President—

7 (1) shall proclaim duty-free entry for 3,3′-

8 diaminobenzidine (Tetraamino Biphenyl), to be ef9 fective with respect to the entry of goods on or after

10 January 1, 1995, and

11 (2) shall take such actions as are necessary to

12 reflect such tariff treatment in Schedule XX, as de-
2

•HR 2870 IH

1 fined in section 2(5) of the Uruguay Round Agree2 ments Act (19 U.S.C. 3501(5).

3 (b) LIQUIDATION OR RELIQUIDATION AND REFUND

4 OF DUTY PAID ON ENTRIES.—

5 (1) LIQUIDATION OR RELIQUIDATION.—Not6 withstanding section 514 of the Tariff Act of 1930

7 (19 U.S.C. 1514) or any other provision of law, and

8 subject to paragraph (2), the Secretary of the Treas9 ury shall liquidate or reliquidate any entry of goods

10 described in subsection (a) that was made on or

11 after January 1, 1995, and before the proclamation

12 is issued under subsection (a), and refund any duty

13 or excess duty that was paid on such entry.

14 (2) REQUESTS.—Liquidation or reliquidation

15 may be made under paragraph (1) with respect to

16 any entry only if a request therefor is filed with the

17 Customs Service, within 180 days after the date of

18 the enactment of this Act, that contains sufficient

19 information to enable the Customs Service—

20 (A) to locate the entry; or

21 (B) to reconstruct the entry if it cannot be

22 located.
3

•HR 2870 IH

1 SEC. 2. DEFINITION.

2 As used in this Act, the term ‘‘entry’’ includes a with3 drawal from warehouse for consumption.

Æ
HomeCuba

# Cuba

160 items

        -    Report  		Cuba Internet Task Force: Final Report	  June 16, 2019 
        -    		Cuba Internet Task Force	   
        -    		Cuba: Title III FAQs (LIBERTAD)	   
        -    		Cuba	  April 23, 2019 
        -    		U.S. Maritime Boundaries: Agreements and Treaties	   
        -    Report  		Cuba	  March 13, 2019 
        -    		Cuba Internet Task Force – December 6, 2018 Meeting Documents	   
        -    		Defending Freedom	   
        -    Report  		Cuba	  June 28, 2018 
        -    Report  		Cuba	  May 29, 2018 

previous page1…1213141516next page

Back to Top